Curis, Inc.
COMPOUNDS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS
Last updated:
Abstract:
The present invention provides methods of treating hematological disorders and solid malignant tumors, using substituted indazole compounds and pharmaceutically acceptable salts thereof. The compounds inhibit IRAK4 and BCL-2 kinases.
Status:
Application
Type:
Utility
Filling date:
21 Jul 2020
Issue date:
5 Nov 2020